Characteristics of fibrin formation and clot stability in individuals with congenital type IIb protein C deficiency

Thrombosis Research

Volumn 129, Issue 4, 2012, Pages

  Foley, J H ^a   Ferris, L ^a   Brummel Ziedins, K E ^a  

^a UNIVERSITY OF VERMONT   (United States)

Author keywords

Carboxypeptidase U; factor XIII; fibrin; protein C deficiency; TAFI; thrombosis

Indexed keywords

ANTITHROMBIN; BLOOD CLOTTING FACTOR 13; FIBRINOGEN; THROMBIN; THROMBIN ACTIVATABLE FIBRINOLYSIS INHIBITOR;

ADULT; AGED; ARTICLE; BLOOD; BLOOD CLOT; BLOOD CLOT LYSIS; CASE REPORT; CONGENITAL TYPE IIB PROTEIN C DEFICIENCY; CONTROLLED STUDY; FEMALE; FIBRIN CLOT; FIBRIN DEPOSITION; FIBRIN FORMATION; FIBRINOLYSIS; HUMAN; MALE; PRIORITY JOURNAL; PROTEIN C DEFICIENCY; THROMBOSIS;

ADULT; AGED; BLOOD COAGULATION; FEMALE; FIBRIN; HUMANS; MALE; PROTEIN C DEFICIENCY;

EID: 84858333667     PISSN: 00493848     EISSN: 18792472     Source Type: Journal    
DOI: 10.1016/j.thromres.2011.12.020     Document Type: Article

References (27)

1. L. Bajzar, R. Manuel, and M.E. Nesheim Purification and Characterization of TAFI, a Thrombin Activatable Fibrinolysis Inhibitor J Biol Chem 270 1995 14477 14484
2. L. Lorand Factor XIII: structure, activation, and interactions with fibrinogen and fibrin Ann N Y Acad Sci 936 2001 291 311
3. S. Matacic, and A.G. Loewy The identification of isopeptide crosslinks in insoluble fibrin Biochem Biophys Res Commun 30 4 1968 356 362
4. Y. Sakata, and N. Aoki Cross-linking of alpha 2-plasmin inhibitor to fibrin by fibrin-stabilizing factor J Clin Invest 65 2 1980 290 297
5. Y. Sakata, and N. Aoki Significance of Cross-Linking of Alpha2-Plasmin Inhibitor to Fibrin in Inhibition of Fibrinolysis and in Hemostasis J Clin Invest 69 1982 536 542
6. W. Wang, M.B. Boffa, L. Bajzar, J.B. Walker, and M.E. Nesheim A Study of the Mechanism of Inhibition of Fibrinolysis by Activated Thrombin-activable Fibrinolysis Inhibitor J Biol Chem 273 42 1998 27176 27181
7. S.R. Poort, F.R. Rosendaal, P.H. Reitsma, and R.M. Bertina A Common Genetic Variation in the 3' Untranslated Region of the Prothrombin Gene Is Associated With Elevated Plasma Prothrombin Levels and an Increase in Venous Thrombosis Blood 88 1996 3698 3703
8. E.M. Conway, K.A. Bauer, S. Barzegar, and R.D. Rosenberg Suppression of Hemostatic System Activation by Oral Anticoagulants in the Blood of Patients with Thrombotic Diathesis J Clin Invest 80 1987 1535 1544
9. M.E. Meltzer, T. Lisman, P.G. de Groot, J.C. Meijers, C.S. le, and C.J. Doggen Venous thrombosis risk associated with plasma hypofibrinolysis is explained by elevated plasma levels of TAFI and PAI-1 Blood 116 1 2010 113 121
10. E.G. Bovill, K.A. Bauer, J.D. Dickerman, P. Callas, and B. West The Clinical Spectrum of Heterozygous Protein C Deficiency in a Large New England Kindred Blood 73 1989 712 717
11. J.A. Tomczak, R.A. Ando, H.G. Sobel, E.G. Bovill, and G.L. Long Genetic analysis of a large kindred exhibiting type I protein C deficiency and associated thrombosis Thromb Res 74 3 1994 243 254
12. S.J. Hasstedt, I.D. Bezemer, P.W. Callas, C.Y. Vossen, W. Trotman, and R.P. Hebbel Cell adhesion molecule 1: a novel risk factor for venous thrombosis Blood 114 14 2009 3084 3091
13. Y. Barenholz, D. Gibbes, B.J. Litman, J. Goll, T.E. Thompson, and F.D. Carlson A Simple Method for the Preparation of Homogeneous Phospholipid Vesicle Biochemistry 16 12 1977 2806 2810
14. Y. Hojima, J.V. Pierce, and J.J. Pisano Hageman Factor Fragment Inhibitor in Corn Seeds: Purification and Characterization Thromb Res 20 1980 149 162
15. M.D. Rand, J.B. Lock, C. van't Veer, D.P. Gaffney, and K.G. Mann Blood clotting in minimally altered whole blood Blood 88 9 1996 3432 3445
16. K.E. Brummel, S.G. Paradis, S. Butenas, and K.G. Mann Thrombin functions during tissue factor-induced blood coagulation Blood 100 1 2002 148 152
17. K.E. Brummel, S. Butenas, and K.G. Mann An Integrated Study of Fibrinogen During Blood Coagulation J Biol Chem 274 32 1999 22862 22870
18. K.E. Brummel-Ziedins, R.F. Branda, S. Butenas, and K.G. Mann Discordant fibrin formation in hemophilia J Thromb Haemost 7 5 2009 825 832
19. A.S. Wolberg Plasma and cellular contributions to fibrin network formation, structure and stability Haemophilia 16 Suppl 3 2010 7 12
20. A. Undas, and R.A. Ariens Fibrin clot structure and function: a role in the pathophysiology of arterial and venous thromboembolic diseases Arterioscler Thromb Vasc Biol 31 12 2011 e88 99
21. J.P. Collet, Y. Allali, C. Lesty, M.L. Tanguy, J. Silvain, and A. Ankri Altered fibrin architecture is associated with hypofibrinolysis and premature coronary atherothrombosis Arterioscler Thromb Vasc Biol 26 11 2006 2567 2573
22. K. Fatah, A. Silveira, P. Tornvall, F. Karpe, M. Blomback, and A. Hamsten Proneness to formation of tight and rigid fibrin gel structures in men with myocardial infarction at a young age Thromb Haemost 76 4 1996 535 540
23. J.D. Mills, R.A.S. Ariëns, M.W. Mansfield, and P.J. Grant Altered fibrin clot structure in the healthy relatives of patients with premature coronary artery disease Circulation 106 15 2002 1938 1942
24. A. Undas, K. Zawilska, M. Ciesla-Dul, A. Lehmann-Kopydlowska, A. Skubiszak, and K. Ciepluch Altered fibrin clot structure/function in patients with idiopathic venous thromboembolism and in their relatives Blood 114 19 2009 4272 4278
25. A. Undas, J. Zalewski, M. Krochin, Z. Siudak, M. Sadowski, and J. Pregowski Altered plasma fibrin clot properties are associated with in-stent thrombosis Arterioscler Thromb Vasc Biol 30 2 2010 276 282
26. R.A. Ariens, H. Philippou, C. Nagaswami, J.W. Weisel, D.A. Lane, and P.J. Grant The factor XIII V34L polymorphism accelerates thrombin activation of factor XIII and affects cross-linked fibrin structure Blood 96 3 2000 988 995
27. N.L. Esmon, W.G. Owen, and C.T. Esmon Isolation of a Membrane-bound Cofactor for Thrombin-catalyzed Activation of Protein C J Biol Chem 257 1982 859 864